Aerie Pharmaceuticals Stock (NASDAQ: AERI)
|Day Range15.14 - 15.24||52 Wk Range4.81 - 15.37||Open / Close15.14 / 15.2||Float / Outstanding48.4M / 49.4M|
|Vol / Avg.625.3K / 1.5M||Mkt Cap751.1M||P/E-||50d Avg. Price13.18|
|Div / Yield-||Payout Ratio-||Total Float48.4M||EPS-0.41|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Aerie Pharmaceuticals (NASDAQ: AERI) through any online brokerage.
The latest price target for Aerie Pharmaceuticals (NASDAQ: AERI) was reported by Citigroup on Monday, August 29, 2022. The analyst firm set a price target for 0.00 expecting AERI to fall to within 12 months (a possible -100.00% downside). 9 analyst firms have reported ratings in the last year.
The stock price for Aerie Pharmaceuticals (NASDAQ: AERI) is $15.2 last updated Today at October 7, 2022, 8:00 PM UTC.
There are no upcoming dividends for Aerie Pharmaceuticals.
Aerie Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 3, 2022.
There is no upcoming split for Aerie Pharmaceuticals.
Aerie Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.